D-lactosyl-β-1,1' N-palmitoyl-D-erythro-sphingosine
| Catalog Number | BL-M001022 |
| CAS Number | 4201-62-1 |
| Description | D-lactosyl-β-1,1' N-palmitoyl-D-erythro-sphingosine, a vital constituent in sphingolipid metabolism, exerts significant influence on cell proliferation and programmed cell death. Its therapeutic applications extend to a diverse range of maladies encompassing cancer, neurodegenerative ailments, and metabolic anomalies. |
| {[VisualName]} |  |
| IUPAC Name | N-[(E,2S,3R)-1-[(2R,3R,4R,5S,6R)-3,4-dihydroxy-6-(hydroxymethyl)-5-[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3-hydroxyoctadec-4-en-2-yl]hexadecanamide |
| Synonyms | LacCer(d18:1/16:0); Cytopylin H; C16 Lactosyl(β) Ceramide (d18:1/16:0); N-(hexadecanoyl)-1-β-lactosyl-sphing-4-enine |
| Molecular Weight | 862.18 |
| Molecular Formula | C46H87NO13 |
| Purity | >99% |
| Appearance | Powder |
| Shelf Life | 1 Year |
| Storage | Store at -20°C |
| Percent Composition | C 64.08%, H 10.17%, N 1.62%, O 24.12% |
| Canonical SMILES | CCCCCCCCCCCCCCCC(=O)NC(COC1C(C(C(C(O1)CO)OC2C(C(C(C(O2)CO)O)O)O)O)O)C(C=CCCCCCCCCCCCCC)O |
| InChI | InChI=1S/C46H87NO13/c1-3-5-7-9-11-13-15-17-19-21-23-25-27-29-35(50)34(47-38(51)30-28-26-24-22-20-18-16-14-12-10-8-6-4-2)33-57-45-43(56)41(54)44(37(32-49)59-45)60-46-42(55)40(53)39(52)36(31-48)58-46/h27,29,34-37,39-46,48-50,52-56H,3-26,28,30-33H2,1-2H3,(H,47,51)/b29-27+/t34-,35+,36+,37+,39-,40-,41+,42+,43+,44+,45+,46-/m0/s1 |
| InChI Key | HLIJNIKSBCIDGO-QKLMXXKVSA-N |
※ Please be kindly noted products are not for therapeutic use. We do not sell to patients.
Related Products
Online Inquiry
